Jim Tananbaum may be the face of healthcare innovation. The founder and CEO of Foresite Capital has help architect many healthcare trends you see today. Foresite is a healthcare dedicated private equity firm.What separates the firm from its competitors is its focus on identifying emerging healthcare leaders and helping them reach full potential.
Jim had already made a name for himself before founding Foresite Capital. Prior to its inception he co-founded two biopharmaceutical companies and two healthcare investment practices. Both of the biopharmaceutical companies became leaders in the industry. GelTex Pharmaceuticals did especially well. The company managed to bring towo drugs to market for less than 80 million dollars. Its lead drug, Renagel, drastically increased revenue. Because of this the company was sold for $1.6 billion.
Jim is also a top of the line investor. He just seems to have a knack for recognizing what has potential and what doesn’t. Over his business career he has ran numerous investments.
Jim founding Foresite was a complete culmination of everything he’d learned in his career. He’d spent close to 30 years as a healthcare entrepreneur and investment strategist before establishing Foresite. He knew he could lead the company to success if he put real effort towards it and built the right team. Foresite has invested in 77 different healthcare companies in biopharmaceuticals, medical services, and diagnostics and genomic sequencing.
Jim is also a scholar. He attended Yale, where he studied math and electrical engineering/computer science. He also possesses a M.D. and M.B.A. from Harvard as well as a M.S. from the Massachusetts Institute of Technology. He knew to achieve the goals he’d set for himself he needed higher learning. Even after decades of working in the industry he still finds joy in what he does. Something most people can only imagine.